✦ LIBER ✦

Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

✍ Scribed by Chouaid Christos, Le Caer Hervé, Locher Chrystelle, Dujon Cecile, Thomas Pascal, Auliac Jean Bernard, Monnet Isabelle, Vergnenegre Alain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Analysis of Erlotinib Versus Chemot

✍ Chouaid, Christos; Le Caer, Hervé; Corre, Romain; Crequit, Jacquy; Locher, Chrys 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 781 KB

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN

✍ C Chouaid; H Lecaer; J Crequit; I Monnet; S Chouabe; C Locher; D Paillotin; JB A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN79 Cost Effectiveness of Erlotinib in

✍ Chouaid, C.; Le Caer, H.; Corre, R.; Crequit, J.; Jullian, H.; Falchero, L.; Duj 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A phase II study of erlotinib in combina

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Randomized open-label non-comparative mu

✍ Auliac, J.B.; Chouaid, C.; Greiller, L.; Monnet, I.; Le Caer, H.; Falchero, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB